Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Morrison

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Microvascular Research|March 1, 1976
Oxygen utilization and coronary vascular reserve in the ischemic myocardium following acute coronary occlusion in the dogJ Grayson, C A Scott, C J Morrison
Biotechnology and Bioengineering|March 20, 1997
Differential stability of proteolytically active and inactive recombinant metalloproteinase in Chinese hamster ovary cellsC J Morrison, W R McMaster, J M Piret
Journal of Medical Microbiology|February 1, 1988
Enhanced oxidative mechanisms in immunologically activated versus elicited polymorphonuclear neutrophils: correlations with fungicidal activityC J Morrison, R A Isenberg, D A Stevens
Advances in Experimental Medicine and Biology|January 1, 1991
Effect of growth conditions on the extracellular production of the aspartic proteinase by Candida albicansM Lam, V Peterkin, E Reiss, et al.
Journal of Clinical Microbiology|June 1, 1997
Rapid identification of Candida species in blood cultures by a clinically useful PCR methodJ H Shin, F S Nolte, C J Morrison
Alternative Therapies in Health and Medicine|July 1, 1995
What's in a word?K D Clouser, D J Hufford, C J Morrison
Biochimica Et Biophysica Acta|December 6, 1995
Analysis of the active site and activation mechanism of the Leishmania surface metalloproteinase GP63M H Macdonald, C J Morrison, W R McMaster
Antimicrobial Agents and Chemotherapy|July 18, 2000
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasisB A Arthington-Skaggs, D W Warnock, C J Morrison
Antimicrobial Agents and Chemotherapy|April 19, 2000
Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazoleT Wu, K Wright, S F Hurst, et al.
Journal of Clinical Microbiology|September 17, 1999
Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicansB A Arthington-Skaggs, H Jradi, T Desai, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Microvascular Research|March 1, 1976
Oxygen utilization and coronary vascular reserve in the ischemic myocardium following acute coronary occlusion in the dogJ Grayson, C A Scott, C J Morrison
Biotechnology and Bioengineering|March 20, 1997
Differential stability of proteolytically active and inactive recombinant metalloproteinase in Chinese hamster ovary cellsC J Morrison, W R McMaster, J M Piret
Journal of Medical Microbiology|February 1, 1988
Enhanced oxidative mechanisms in immunologically activated versus elicited polymorphonuclear neutrophils: correlations with fungicidal activityC J Morrison, R A Isenberg, D A Stevens
Advances in Experimental Medicine and Biology|January 1, 1991
Effect of growth conditions on the extracellular production of the aspartic proteinase by Candida albicansM Lam, V Peterkin, E Reiss, et al.
Journal of Clinical Microbiology|June 1, 1997
Rapid identification of Candida species in blood cultures by a clinically useful PCR methodJ H Shin, F S Nolte, C J Morrison
Alternative Therapies in Health and Medicine|July 1, 1995
What's in a word?K D Clouser, D J Hufford, C J Morrison
Biochimica Et Biophysica Acta|December 6, 1995
Analysis of the active site and activation mechanism of the Leishmania surface metalloproteinase GP63M H Macdonald, C J Morrison, W R McMaster
Antimicrobial Agents and Chemotherapy|July 18, 2000
Quantitation of Candida albicans ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasisB A Arthington-Skaggs, D W Warnock, C J Morrison
Antimicrobial Agents and Chemotherapy|April 19, 2000
Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazoleT Wu, K Wright, S F Hurst, et al.
Journal of Clinical Microbiology|September 17, 1999
Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicansB A Arthington-Skaggs, H Jradi, T Desai, et al.
Pageof 4